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Abstract
Background: Leptin and its soluble receptor (sOB-R) are important to regulation of body
composition but there are no data on the developmental variations in these plasma variables and
their relationship with body composition measurements,
Methods: Weight, length, and body composition (bone, fat and lean mass) by dual energy
absorptiometry, and plasma variables were measured in healthy infants at 2, 4, 8 and 12 months.
Results: 15 whites and 29 African Americans (21 males and 23 females) with mean birth weight
3357 +/- 45 (SEM) g and gestation of 39.3 +/- 0.17 weeks were studied. The overall Z score for
weight, length and weight for length during the study were 0.00 +/- 0.15, -0.08 +/- 0.11 and 0.12 +/
- 0.14 respectively. With increasing age, plasma leptin (1.0 to 18.2, median 5.5 ng/mL) and sOB-
R:leptin molar ratio (10.1 to 247.4, median 59.9) were lowered (r = -0.47, p < 0.01; and r = -0.37,
p < 0.05 respectively), best predicted by   weight Z score and percentage of fat mass, and higher in
African American and female. Presence of body composition measurements eliminated the race
and gender effect on the plasma variables. Plasma sOB-R (49.5 to 173.9, median 81.3 ng/mL) did
not change significantly with age and was correlated and predicted only by body composition
measurements.
Conclusion: In healthy growing infants, plasma leptin but not sOB-R decreases with age. Gender,
race and anthropometric measurements are additional physiological determinants predictive of
plasma leptin and the receptor:ligand ratio. However, body composition is the only variable that
can predict plasma leptin and its soluble receptor and the receptor: ligand ratio; and body
composition measurements eliminated the race and gender effect on these plasma variables.
Background
Hormonal responses from the gastrointestinal tract, brain
and body tissues associated with dietary intake and regu-
lation of nutritional status and body weight are well
described in adults [1-3]. There are increasing data indi-
cating that similar hormonal changes can occur in chil-
dren and infants [4-9]. Understanding their relationship
with body composition measurements as indicators of tis-
sue accretion might shed light on the physiological basis
to integrate nutrition support, growth and tissue accre-
tion.
Concentration of circulating leptin, an adipocyte hor-
mone, reflects the amount of energy stored in adipose tis-
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sue and is considered a marker of nutritional status [1-3].
Leptin is bound to the soluble leptin receptor (sOB-R) in
the circulation, which modulates steady state leptin levels
by preventing the hormone from degradation and clear-
ance [10], and sOB-R:leptin ratio may be considered a
marker of bioavailable leptin.
In the neonate, dramatic changes in circulating leptin and
sOB-R with a decrease in leptin by as much as 80% [5-7]
and increase in sOB-R by >5 folds [7] are reported. At
birth, weight and body mass index are positively corre-
lated with plasma leptin concentrations [5,6,8], and one
report indicated that sOB-R is inversely related to birth
weight [7]. This pattern of changes in leptin and its sOB-R
and their relationship with body weight and body mass
index presumably reflect the loss of placental contribu-
tion for leptin and the physiologic adaptation to lower
availability of free leptin, thereby allowing an increase in
energy intake to initiate the phase of rapid postnatal
growth.
Infancy is the period of most rapid postnatal growth and
one report in healthy but relatively malnourished infants
with average weight for age Z score of -1.9 at 52 weeks
shows a decrease in plasma leptin from birth to 1 year.
Changes in plasma sOB-R in infants beyond the immedi-
ate newborn period are not well defined. Furthermore, the
relationship between body composition measurements as
reflection of tissue accretion, with these plasma variables
is not known. The aim of this study is to define the devel-
opmental variations in circulating leptin and sOB-R in
healthy infants specifically the physiologic determinants
including age, gender, race, and measures of growth or
body composition on these plasma variables.
Methods
This is a cross sectional design with anthropometry, body
composition and circulating leptin and sOB-R measure-
ments performed on the same day for each subject. All
subjects were singleton infants between 37 and 42 weeks
gestation with appropriate birth weight for gestation [11]
and studied at approximately 2, 4, 8 and 12 months.
None of the infants had major malformation or medical
or surgical conditions that may affect long term growth.
Weight, length, and head circumference were measured
using standard methods [12,13]. Infants were weighed in
the nude to the nearest 5 g using an electronic scale (Seca,
Toledo, OH) that was calibrated daily. Length was meas-
ured in duplicate to the nearest 0.1 cm with the infant in
a recumbent position using O'Leary Lengthboard ™
(Ellard Instruments Ltd, Seattle, WA).
Body composition is indicated by total body bone mass as
bone mineral content, and fat and lean mass were deter-
mined by fan beam dual energy X-ray absorptiometry
(DXA) (QDR 4500A, Hologic Inc, Waltham, MA). Scan
acquisition techniques have been reported elsewhere [14].
Each infant was wrapped in cotton blanket for the scan.
The use of a diaper with or without light undergarment for
the infant was allowed prior to bundling the infant in the
cotton blanket. However, all coverings were weighed with
an electronic scale and the weight recorded. Scan analysis
used software vKHS11 validated by carcass analysis
[15,16]. Only scans with no significant movement arti-
facts [17] were included in data analysis. In our labora-
tory, the precision error [18] from duplicate infant whole
body scans for bone, fat and lean mass were 2.6, 7.1 and
2.5% respectively. Bone, fat and lean mass also were
expressed as a percent of DXA measured total body mass.
Plasma samples for the measurement of leptin and sOB-R
were kept at -70°C until measurement. Plasma leptin and
sOB-R were measured using the commercial enzyme
linked immunoassay kits from the same manufacturer
(Diagnostic Systems Laboratories, Inc., Webster, TX).
Recombinant human leptin and human soluble leptin
receptor were used as standards and controls in the respec-
tive assays. In our laboratory, the coefficient variation of
the leptin assay was 9% and for the sOB-R assay was 5%.
Ethical approval for the study was obtained from the Insti-
tutional Review Board for Human Investigations at Wayne
State University, Detroit, MI. Written informed consent
was obtained from the parent of each infant.
Statistical analysis
The absolute values of anthropometric measurements
were normalized by expression as Z scores using the age
and gender matched normative data from the National
Center for Health Statistics [19]. The absolute values for
bone, fat and lean mass were transformed to a percentage
of total weight. Plasma sOB-R:leptin molar ratio was cal-
culated according to the molecular mass of 130 kD for
sOB-R and 16 kD for leptin. All statistical analysis
included the use of absolute and transformed measure-
ments.
Pearson's correlation was used to determine the relation-
ship for each plasma parameter (leptin, sOB-R and sOB-
R:leptin ratio) with each anthropometric and each DXA
parameter. Analysis of covariance was used to determine
the relation of gender, race and age to plasma measure-
ments. Stepwise regression analysis was used to determine
the relative contribution from each of the physiologic var-
iables in the prediction of plasma leptin, sOB-R, and sOB-
R:leptin ratio. By design, the use of absolute and percent-
age of body composition measurement was mutually
exclusive in regression analysis, as well as the use of
anthropometric and DXA measurements, since body
Nutrition Journal 2007, 6:11 http://www.nutritionj.com/content/6/1/11
Page 3 of 7
(page number not for citation purposes)
weight is the sum of body composition measurements;
and both weight and length are predictive of various
aspects of body composition [20-22]. Neither age nor gen-
der was entered as independent variables with any analy-
sis using Z scores since the Z scores were standardized to
age and gender.
All values are mean +/- SEM. Statistical tests were per-
formed with SPSS Version 13.5 for Windows (SPSS Inc.,
Chicago, IL) at an adopted significance level of 0.05 and
were two-tailed.
Results
There were 44 infants with mean birth weight 3357 +/- 45
g and gestation of 39.3 +/- 0.17 weeks, with 15 whites and
29 African Americans, and 21 (7 white) males and 23 (8
white) females. Anthropometric and DXA measurements
and blood collection were performed at 56 +/- 0.8, 112 +/
- 1.0, 240 +/- 1.5, and 366 +/- 2.7 days. Age was positively
correlated with all absolute values of anthropometric and
DXA measurements (p < 0.01 for all comparisons).
Weight for age Z score (WAZ) decreased (r = -0.36, p =
0.02) but recumbent length for age (HAZ) and weight for
length (WHZ) Z scores were not significantly different
with age. The overall WAZ, HAZ and WHZ were 0.00 +/-
0.15 and -0.08 +/- 0.11, and 0.12 +/- 0.14 respectively.
Bone mass as a percentage of total mass was increased (r
= 0.58, p < 0.01) but the percentages of fat and lean mass
did not change significantly with age. The overall percent-
ages for bone, fat and lean mass were 2.5 +/- 0.04, 26.3 +/
- 0.92, and 71.2 +/- 0.93 respectively.
Plasma leptin concentrations varied from 1.0 to 18.2
(median 5.5) ng/mL and decreased with age (r = -0.47, p
< 0.01) (Fig 1). The relationships between plasma leptin
concentrations and anthropometric measurements are
shown in Table 1. Z scores were better correlated with
plasma leptin than absolute measurements. The relation-
ships between plasma leptin concentrations and body
composition measurements are shown in Table 2. Body
compositions as percentage of total weight were better
correlated with plasma leptin than absolute measure-
ments. Percent fat mass was positively correlated with
plasma leptin although both absolute and percent bone
and lean masses were negatively correlated with plasma
leptin. African American infants had higher plasma leptin
concentrations (p < 0.05) after adjustment for age at
study. There was no race and gender interaction effect on
plasma leptin. Neither race nor gender affected absolute
or percent fat mass.
Plasma sOB-R concentrations varied from 49.5 to 173.9
(median 81.3) ng/mL, did not change significantly with
age (Fig 2) and were not significantly correlated with
plasma leptin concentrations. There was no correlation
between plasma sOB-R with any anthropometric meas-
urements (Table 1). Plasma sOB-R was positively corre-
lated with fat mass and negatively correlated with percent
lean mass (Table 2). Plasma sOB-R was not affected by
race or gender.
Plasma sOB-R:leptin molar ratio varied from 10.1 to
247.4 (median 59.9) and decreased with age (r = -0.37, p
= 0.05). Weight and WAZ were the only anthropometric
variables significantly correlated with plasma sOB-R:lep-
tin ratio. Whereas, plasma sOB-R:leptin ratio was posi-
tively correlated with absolute and percent fat mass, but
negatively correlated with lean mass and percent lean and
bone mass. The relationship was stronger based on per-
cent lean or fat mass than the absolute mass (Table 2).
There was no race or gender effect on plasma sOB-R:leptin
ratio.
Weight or WAZ had positive and length or HAZ had neg-
ative predictive effect on plasma leptin. Females have
higher plasma leptin concentrations and sOB-R:leptin
ratio compared to males. None of the physiologic varia-
Table 2: Correlation of plasma leptin, leptin soluble receptor 
(sOB-R), and sOB-R:Leptin ratio with body composition 
measurements as absolute values or as percentage of total 
weight in term infants
Leptin ng/mL Leptin soluble receptor 
ng/mL
sOB-R:Leptin 
molar ratio
Absolute measurements
Bone -0.32† 0.20 -0.21
Lean -0.43* 0.17 -0.34†
Fat 0.16 0.47* 0.38†
As percentage of total weight
Bone -0.33† -0.16 -0.33†
Lean -0.50* -0.33† -0.66*
Fat 0.52* 0.31 0.66*
Pearson correlation with 2 tailed significance: * p ≤ 0.01, † p ≤ 0.05
Table 1: Correlation of plamsa leptin, leptin soluble receptor 
(sOB-R), and sOB-R:Leptin ratio with anthopometric 
measurements and their Z scores in term infants
Leptin ng/mL Leptin soluble 
receptor ng/mL
sOB-
R:Leptin 
molar ratio
Absolute measurements
Weight -0.29 0.29 -0.14
Length -0.44* 0.23 -0.30
Weight:length ratio 0.45* -0.25 0.30
Z scores
Weight 0.58* 0.22 0.66*
Length 0.05 0.29 0.21
Weight for length 0.57* 0.17 0.62*
Pearson correlation with 2 tailed significance: * p ≤ 0.01
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bles entered into analysis with anthropometric measure-
ments were predictive for plasma soluble receptor
concentration (Table 3).
The absolute or percent fat mass was consistently predic-
tive of plasma leptin, sOB-R and sOB-R:leptin molar ratio
(Table 4). Percentage of body composition component
was slightly better than the absolute values in the predic-
tion of the plasma variables. Age was predictive of plasma
leptin and sOB-R:leptin ratio. Presence of body composi-
tion measurements eliminated any race or gender effect
on plasma sOB-R and sOB-R:leptin ratio.
Discussion
Study of leptin and its regulation has demonstrated its
importance as an integral part of homeostatic mechanism
in the regulation of body weight [1-3]. However, it is not
known whether this is applicable to all life stages and
what changes it may have during growth in which weight
gain and tissue accretion rather than maintenance of body
weight is the physiologic norm.
To our knowledge, this is the first report of the relation-
ship of the circulating leptin and sOB-R concentrations to
various physiological variables of growth and body com-
position specifically, bone, fat and lean masses, during
infancy. Age appears to be a major physiologic determi-
nant of plasma leptin concentrations. It is decreased dur-
ing infancy in those with normal age and gender specific
weight and length Z scores as indicated by our data, and is
also decreased in infants with poor postnatal growth dur-
ing longitudinal measurement of plasma leptin from cord
blood and at 8, 16 and 52 weeks [9]. In this study, the ini-
tial measurement of circulating leptin and its soluble
receptor at 2 months likely eliminated the confounding
factors of placental leptin [23], the initial physiologic
adaptation that occurs commonly with other endocrine
systems [24], and the apparent transient increase in
plasma leptin during the first weeks after birth observed
by some [25,26] but not by other [9] investigators. In the
two reports on postnatal increase in plasma leptin con-
centration, one reported an increase in plasma leptin at 30
days which was significantly correlated with interval
weight gain [25] but no data was available beyond 30
days. In the other report, plasma leptin concentration was
higher in term versus preterm infants up to 30 days but
there was no significant difference between groups at 90
days. The increase in plasma leptin was correlated with
weight gain and increase in subcutaneous tissue [26].
Whether this transient increase in plasma leptin is related
to changes in leptin transport, metabolism or clearance is
not known.
Plasma sampling in our study tend to correspond to ages
when milk intake is the exclusive or dominant source of
nutrient, namely at 2 and 4 months, and when mixed diet
becomes increasingly established at 8 and 12 months
respectively. Our preliminary data suggest that usual die-
tary intake in healthy and normally grown infants proba-
bly does not affect plasma leptin or its soluble receptor
concentrations, although determination of the relation-
ship between leptin and its receptor with details of nutri-
tional intake was not the primary goal of this study and
further studies are needed.
Anthropometric and body composition measurements
are related to and predictive of plasma leptin. This is con-
sistent with other reports that plasma leptin is correlated
Variation in plasma leptin soluble receptor (sOB-R) concen-tr t ons with age in healthy infantsFigure 2
Variation in plasma leptin soluble receptor (sOB-R) concen-
trations with age in healthy infants.
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with actual [26] or gain [25,26] in body weight, and actual
[8,9] and changes [9] in body mass index, and with indi-
rect indicators of body fat such as subcutaneous skinfold
thicknesses [7,25,26]. Plasma leptin was also found to dis-
criminate both the long term and changes in energy status
based on skinfold thickness [9].
The consistent relation between the plasma leptin partic-
ularly with fat mass is supportive of adipose tissue being
the major source of circulating leptin. The negative corre-
lation of percent bone mass and percent lean mass with
plasma leptin is not surprising since an increase in the
proportion of fat mass is generally correlated with
decreased proportion of lean and bone mass. However, a
direct relation between plasma leptin and other tissue
mass may be possible since increasing numbers of non-
adipose tissues including skeletal muscle [27], chondro-
cyte [28] and human osteoblast [29] are reported to syn-
thesize leptin and may have cellular leptin receptor forms
with physiological activity in experimental models. In any
case, the exact role of leptin in the changes in skeletal mus-
cle and bone in humans remain to be defined.
Our data show elevated sOB-R concentrations throughout
infancy. Other investigators have reported persistently ele-
vated sOB-R concentrations during early childhood [30].
The positive relation between plasma sOB-R and fat mass
may be indicative of the increased membrane-bound lep-
tin receptor forms, the source of sOB-R. The negative cor-
relation of percent lean mass with plasma sOB-R is
consistent with the generally inverse relation between per-
cent lean and fat mass.
The correlation between these plasma variables with
anthropometric or body composition measurements were
better with the use of Z scores rather than absolute meas-
urements, with fat percent rather than absolute fat mass,
and generally better with body composition, specifically
Table 4: Prediction values of physiologic variables including age, race, gender, and absolute values (left 2 columns) or percent bone, 
lean and fat mass (right 2 columns) for plasma leptin and leptin soluble receptor concentrations, and leptin soluble receptor:leptin 
molar ratio
Dependent variable – plasma leptin (ng/mL)
Independent variables: R2 0.37 Beta (p) Independent variables: R2 0.37 Beta (p)
Age (d) -0.65 (0.001) Age (d) -0.34 (0.01)
Fat (g) 0.44 (0.003) Fat% 0.42 (0.003)
Dependent variable – plasma soluble leptin receptor (ng/mL)
Independent variables: R2 0.22 Independent variables: R2 0.43
Fat (g) 0.47 (0.004) BMC% -0.63 (0.004)
Lean% -14.1 (0.001)
Fat% -13.8 (0.001)
Dependent variable – plasma soluble leptin receptor : leptin ratio
Independent variables: R2 0.54 Independent variables: R2 0.59
Age (d) -0.71 (0.001) BMC% -0.59 (0.002)
Fat (g) 0.72 (0.001) Lean% -7.04 (0.02)
Fat% -6.42 (0.03)
Table 3: Prediction values of physiologic variables including age, race, gender, and absolute values (left 2 columns) or age and gender 
specific Z scores (right 2 columns) of anthropometric measurements for plasma concentrations of leptin and leptin soluble receptor*, 
and leptin soluble receptor:leptin molar ratio.
Dependent variable – plasma leptin (ng/mL)
Independent variables: R2 0.49 Beta (p) Independent variables: R2 0.46 Beta (p)
Weight (g) 1.87 (0.001) Weight Z score 0.83 (0.001)
Length (cm) -2.17 (0.001) Length Z score -0.44 (0.01)
Gender (Female = 1, male = 0) 0.27 (0.03)
Dependent variable – plasma soluble leptin receptor : leptin molar ratio
Independent variables: R2 0.50 Independent variables: R2 0.44
Age (d) -0.75 (0.001) Weight Z score 0.66 (0.001)
Weight (g) 1.51 (0.001)
Gender (Female = 1, male = 0) 0.39 (0.01)
* None of the physiologic variables was predictive for plasma soluble receptor concentration.
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fat mass, rather than anthropometric measurements. Thus
the use of standardized rather than absolute measure-
ments of anthropometry and body composition is indi-
cated in future studies on the interplay of leptin and its
receptor with different nutrition support in growing sub-
jects. Furthermore, body composition measurements are
probably more sensitive indicators of leptin production
and bioactivity.
It is interesting that even with the limited sample size, our
findings of higher leptin concentration in African Ameri-
can infants independent of fat mass is consistent with the
report on adult males and females that non-Hispanic
blacks have slightly higher values compared to non-His-
panic whites or Mexican Americans [31]. Our data of
higher plasma leptin concentration in female infants also
are consistent with the presence of sexual dimorphism
[9,32]. Furthermore, our data show that race and gender
effects were eliminated in the presence of body composi-
tion measurements, presumably body composition meas-
urements more specifically reflect the source of leptin and
its receptors. Our data indicate that variations in plasma
sOB-R are independent of race, gender or age but are pre-
dicted by body composition measurements.
Complexes of leptin with sOB-R reflect a molecular ratio
of 1:1 [33] and reached a median value of >10 as early as
3 days after birth because of a decrease in circulating lep-
tin with an accompanied increase in sOB-R [7]. Our data
indicated that plasma sOB-R:leptin ratios remained >10
throughout infancy. Limited data indicate the high
plasma sOB-R:leptin ratios may persist until 2 to 3 years
[30]. It is possible that high circulating concentrations of
sOB-R may block leptin function by its competition with
the membrane receptor for the ligand, which in turn may
be an important stimulus for energy uptake in the rapidly
growing infant or in other conditions with a high energy
demand. However, the decreasing sOB-R:leptin ratio dur-
ing later infancy is presumably associated with increasing
bioavailable leptin, and is consistent with slowing of
growth [19] and tissue accretion [20-22].
Our report represents an exploratory step to determine the
developmental variations of plasma leptin and its soluble
receptor during the period of most rapid postnatal growth
when the body weight and tissue accretion triples over a
one year period. These data when coupled with the body
composition measurements are critical to the design of
future studies to determine the interplay of leptin and its
receptors with nutrition support and the regulation of
growth and tissue accretion.
Conclusion
We conclude that in healthy growing infants, plasma lep-
tin and sOB-R:leptin ratio but not sOB-R decreases with
age. Body composition is the only variable that can pre-
dict plasma leptin and its soluble receptor and the recep-
tor:ligand ratio, and body composition measurements
eliminate the race and gender effect on these plasma vari-
ables. Based on limited size of subgroups in this study, the
race and gender effect on these plasma variables appears
to be consistent with that for adults.
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